bridged pentacyclic skeleton from Xylopia vielana Support ......Fig. S18 IR (KBr disc) spectrum of...
Transcript of bridged pentacyclic skeleton from Xylopia vielana Support ......Fig. S18 IR (KBr disc) spectrum of...
Support information for
Xylopsides AD, four rare guaiane dimers with two unique
bridged pentacyclic skeleton from Xylopia vielana
Yang-Guo Xie, ‡a Yi-Gong Guo, ‡a Guo-Jing Wu,a Sheng-Lan Zhu,a Tao-Fang Cheng,a Yu Zhang,a Shi-Kai Yan,a, * Hui-Zi Jin, * a,c and Wei-Dong Zhang* a, b, d
a Department of Natural Product Chemistry, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China
b Institute of Interdisciplinary Sciences, Shanghai University of Tradictional Chinese Medicine, Shanghai 201203, China
c Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University,
Shanghai 200240, China
d School of Pharmacy, Second Military Medical University, Shanghai, 200433, China
‡ These authors contributed equally.
Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry.This journal is © The Royal Society of Chemistry 2018
ContentsFig. S1 1H NMR spectrum (500 MHz, Chloroform-d) of compound 1Fig. S2 13C NMR spectrum (125 MHz, Chloroform-d) of compound 1Fig. S3 DEPT spectrum (125 MHz, Chloroform-d) of compound 1Fig. S4 1H-1H COSY spectrum (500 MHz, Chloroform-d) of compound 1Fig. S5 HSQC spectrum (500 MHz, Chloroform-d) of compound 1Fig. S6 HMBC spectrum (500 MHz, Chloroform-d) of compound 1Fig. S7 NOESY spectrum (500 MHz, Chloroform-d) of compound 1Fig. S8 HR-ESI-MS spectrum of compound 1Fig. S9 IR (KBr disc) spectrum of compound 1Fig. S10 1H NMR spectrum (500 MHz, Chloroform-d) of compound 2Fig. S11 13C NMR spectrum (125 MHz, Chloroform-d) of compound 2Fig. S12 DEPT spectrum (125 MHz, Chloroform-d) of compound 2Fig. S13 1H-1H COSY spectrum (500 MHz, Chloroform-d) of compound 2Fig. S14 HSQC spectrum (500 MHz, Chloroform-d) of compound 2Fig. S15 HMBC spectrum (500 MHz, Chloroform-d) of compound 2Fig. S16 NOESY spectrum (500 MHz, Chloroform-d) of compound 2Fig. S17 HR-ESI-MS spectrum of compound 2Fig. S18 IR (KBr disc) spectrum of compound 2Fig. S19 1H NMR spectrum (500 MHz, Chloroform-d) of compound 3Fig. S20 13C NMR spe20ctrum (125 MHz, Chloroform-d) of compound 3Fig. S21 DEPT spectrum (125 MHz, Chloroform-d) of compound 3Fig. S22 1H-1H COSY spectrum (500 MHz, Chloroform-d) of compound 3Fig. S23 HSQC spectrum (500 MHz, Chloroform-d) of compound 3Fig. S24 HMBC spectrum (500 MHz, Chloroform-d) of compound 3Fig. S25 NOESY spectrum (500 MHz, Chloroform-d) of compound 3Fig. S26 HR-ESI-MS spectrum of compound 3Fig. S27 IR (KBr disc) spectrum of compound 3Fig. S28 1H NMR spectrum (500 MHz, Chloroform-d) of compound 4Fig. S29 13C NMR spectrum (125 MHz, Chloroform-d) of compound 4Fig. S30 DEPT spectrum (125 MHz, Chloroform-d) of compound 4Fig. S31 1H-1H COSY spectrum (500 MHz, Chloroform-d) of compound 4Fig. S32 HSQC spectrum (500 MHz, Chloroform-d) of compound 4Fig. S33 HMBC spectrum (500 MHz, Chloroform-d) of compound 4Fig. S34 NOESY spectrum (500 MHz, Chloroform-d) of compound4Fig. S35 HR-ESI-MS spectrum of compound 4Fig. S36 IR (KBr disc) spectrum of compound 4Fig. S37 CD spectrum of compounds 1 and 2
Fig. S38 Key1H-1H COSY and NOESY correlations of 3Fig. S39 CD spectrum of compounds 3 and 4Fig. S40 The dose inhibition curve of NO produced by compound 4. The data were obtained from three independent experiments and expressed as the means ± SEM.Fig S41 The TIC and BPC spectrum of the crude extracts from the roots of Xylopia vielana.Fig S42 The HRESIMS of compound 1Fig S43 The HRESIMS of compound 2Fig S44 The HRESIMS of compound 3Fig S45 The HRESIMS of compound 4
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5f1 (ppm)
-500
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
6000
6500
7000
7500
8000
XYG-X-78.1.1.fid
XYG-X-78.1 1H NMR
2.92
2.98
3.00
2.95
1.68
3.17
2.95
2.90
2.99
0.92
0.85
0.99
0.99
1.09
0.81
1.44
0.77
0.96
0.92
0.99
1.00
0.9205
0.9323
0.9847
0.9980
1.3076
1.3110
1.4780
1.8153
1.8505
1.8995
1.9020
1.9384
1.9423
1.9845
2.1849
2.1905
2.1938
2.2117
2.2166
2.3575
2.3636
2.3860
2.4069
2.5614
2.5740
2.5910
2.6248
2.6501
2.6567
2.6621
2.6773
2.9205
2.9550
3.3621
3.3967
3.5106
3.5435
5.2627
Fig. S1 1H NMR spectrum (500 MHz, Chloroform-d) of compound 1
102030405060708090100110120130140150160170180190200210f1 (ppm)
-100
0
100
200
300
400
500
600
700
800
900
1000
1100
1200
XYG-X-78.1.2.fid
XYG-X-78.1 C13 NMR
14.01
19.02
22.01
22.32
22.51
22.79
23.20
27.55
28.22
29.46
30.17
47.39
50.34
52.32
54.54
62.21
62.45
73.87
127.91
131.92
133.51
140.87
142.94
143.17
145.05
174.00
203.74
204.95
206.87
Fig. S2 13C NMR spectrum (125 MHz, Chloroform-d) of compound 1
OO
O
HH
H
OO
O
HH
H
5101520253035404550556065707580859095100105110115120125130f1 (ppm)
-300
-250
-200
-150
-100
-50
0
50
100
150
200
250
300
350
400
450
XYG-X-78.1.3.fid
XYG-X-78.1 DEPT 135
14.02
19.02
22.01
22.32
22.51
22.79
23.20
27.55
28.23
29.46
30.17
47.39
50.34
52.32
62.45
73.87
127.91
Fig. S3 DEPT spectrum (125 MHz, Chloroform-d) of compound 1
0.40.60.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.4f2 (ppm)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
f1 (ppm)
XYG-X-78.1.4.ser
XYG-X-78.1 1H 1H COSY
Fig. S4 1H-1H COSY spectrum (500 MHz, Chloroform-d) of compound 1
OO
O
HH
H
OO
O
HH
H
0.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.2f2 (ppm)
10
20
30
40
50
60
70
80
90
100
110
120
f1 (ppm)
XYG-X-78.1.5.ser
XYG-X-78.1 HSQC
Fig. S5 HSQC spectrum (500 MHz, Chloroform-d) of compound 1
0.00.51.01.52.02.53.03.54.04.55.05.5f2 (ppm)
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
f1 (ppm)
XYG-X-78.1.6.ser
XYG-X-78.1 HMBC
Fig. S6 HMBC spectrum (500 MHz, Chloroform-d) of compound 1
OO
O
HH
H
OO
O
HH
H
1.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.4f2 (ppm)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
f1 (ppm)
XYG-X-78.1.7.ser
XYG-X-78.1 NOE
Fig. S7 NOESY spectrum (500 MHz, Chloroform-d) of compound 1
Fig. S8 HR-ESI-MSspectrum of compound 1
OO
O
HH
H
Fig. S9 IR (KBr disc) spectrum of compound 1
1.01.52.02.53.03.54.04.55.05.56.06.57.0f1 (ppm)
-100
0
100
200
300
400
500
600
700
800
900
1000
1100
1200
XYG-X-59.1.fid
XYG-X-59 1H NMR
3.31
3.08
2.92
3.08
3.20
2.61
1.49
2.41
1.96
2.76
1.26
0.86
1.06
1.00
0.69
1.11
1.00
0.85
0.92
0.9093
0.9229
1.0257
1.0396
1.4214
1.4462
1.4496
1.4714
1.5203
1.8898
2.0278
2.3549
2.4880
2.4902
2.4956
2.6068
2.6200
2.6361
2.9333
2.9648
2.9994
3.4092
3.4437
5.3789
6.0621
Fig. S10 1H NMR spectrum (500 MHz, Chloroform-d) of compound 2
O
OOO
HOH H
H
102030405060708090100110120130140150160170180190200210f1 (ppm)
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
12000
13000
14000
15000
XYG-X-59.2.fid
XYG-X-59 C13 NMR
14.09
14.80
17.13
17.33
19.03
20.00
21.30
21.77
22.36
22.55
22.66
23.25
24.71
26.64
27.48
28.09
28.27
29.33
29.67
31.90
40.35
46.53
47.43
52.91
53.65
60.94
61.88
73.46
76.73 CDCl3
76.99 CDCl3
77.24 CDCl3
85.06
85.54
104.11
115.04
120.35
125.11
131.86
142.10
143.17
145.29
155.38
174.14
203.78
206.82
Fig. S11 13C NMR spectrum (125 MHz, Chloroform-d) of compound 2
101520253035404550556065707580859095100105110115120125f1 (ppm)
-1500
-1000
-500
0
500
1000
1500
2000
XYG-X-59.3.fid
XYG-X-59 DEPT 135
14.80
19.03
21.78
22.37
22.56
23.25
24.71
26.64
27.48
28.10
28.27
40.35
47.43
52.91
61.88
73.46
77.19 CDCl3
120.35
125.10
Fig. S12 DEPT spectrum (125 MHz, Chloroform-d) of compound 2
O
OOO
HOH H
H
O
OOO
HOH H
H
0.60.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.65.8f2 (ppm)
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
f1 (ppm)
XYG-X-59.4.ser
XYG-X-59 1H 1H COSY
Fig. S13 1H-1H COSY spectrum (500 MHz, Chloroform-d) of compound 2
0.51.01.52.02.53.03.54.04.55.05.56.0f2 (ppm)
10
20
30
40
50
60
70
80
90
100
110
120
130
f1 (ppm)
XYG-X-59.5.ser
XYG-X-59 HSQC
Fig. S14 HSQC spectrum (500 MHz, Chloroform-d) of compound 2
O
OOO
HOH H
H
O
OOO
HOH H
H
0.51.01.52.02.53.03.54.04.55.05.56.0f2 (ppm)
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
f1 (ppm)
XYG-X-59.6.ser
XYG-X-59 HMBC
Fig. S15 HMBC spectrum (500 MHz, Chloroform-d) of compound 2
0.51.01.52.02.53.03.54.04.55.05.56.0f2 (ppm)
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
f1 (ppm)
XYG-X-59.7.ser
XYG-X-59 NOE
Fig. S16 NOESY spectrum (500 MHz, Chloroform-d) of compound 2O
OOO
HOH H
H
O
OOO
HOH H
H
O
OOO
HOH H
H
Fig. S17 HR-ESI-MSspectrum of compound 2
Fig. S18 IR (KBr disc) spectrum of compound 2
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5f1 (ppm)
0
500
1000
1500
2000
2500
3000
3500
4000
XYG-X-90.1.fid
XYG-X-90 1H NMR
3.35
3.23
1.38
1.61
3.07
1.26
3.28
6.46
3.30
3.11
2.12
0.93
1.20
1.17
1.42
0.76
1.08
1.06
0.99
1.04
1.00
0.8725
0.8946
0.9059
0.9193
0.9882
1.0222
1.0353
1.2373
1.2515
1.2615
1.2712
1.3672
1.3773
1.3819
1.3854
1.3902
1.3947
1.3983
1.4030
1.4114
1.4159
1.4207
1.4249
1.4324
1.4372
1.4691
1.4724
1.5604
1.5660
1.5710
1.5756
1.5871
1.5925
1.5979
1.6545
1.6582
1.7363
1.7421
1.7495
1.7562
1.7627
1.7711
1.7772
1.7835
1.7907
1.7976
1.8006
1.8045
1.8068
1.8106
1.8457
1.8480
1.8520
1.8542
1.9156
1.9198
1.9318
1.9358
1.9464
1.9507
1.9627
1.9666
2.1794
2.1849
2.1926
2.2015
2.2080
2.2173
2.2224
2.2408
2.2456
2.3564
2.3786
2.4008
2.5419
2.5708
2.5747
2.5788
2.5901
2.5983
2.6051
2.6214
2.6440
2.6594
2.6907
2.8107
2.8165
2.8274
2.8332
3.2226
3.2552
3.3159
3.3469
5.3945
5.3989
5.4032
Fig. S19 1H NMR spectrum (500 MHz, Chloroform-d) of compound 3
0102030405060708090100110120130140150160170180190200210220230240f1 (ppm)
-50
0
50
100
150
200
250
300
350
400
450
500
550
600
650
700
750XYG-X-90.2.fid
XYG-X-90 C13 NMR
14.67
14.91
21.75
22.46
22.48
22.89
23.09
28.40
30.06
30.59
40.90
48.49
49.41
50.66
50.75
58.69
60.69
64.02
72.99
126.37
133.22
134.29
134.73
139.02
140.29
140.38
142.65
205.79
206.01
Fig. S20 13C NMR spectrum (125 MHz, Chloroform-d) of compound 3
O
OH
H
HHH
O
OH
H
HHH
5101520253035404550556065707580859095100105110115120125130f1 (ppm)
-3500
-3000
-2500
-2000
-1500
-1000
-500
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
XYG-X-90.3.fid
XYG-X-90 DEPT 135
14.67
14.91
21.75
22.46
22.48
22.49
22.89
23.09
28.40
30.06
30.59
40.90
48.49
49.41
50.66
50.75
58.69
64.02
72.99
126.37
Fig. S21 DEPT spectrum (125 MHz, Chloroform-d) of compound 3
0.60.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.6f2 (ppm)
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
f1 (ppm)
XYG-X-90.4.ser
XYG-X-90 1H 1H COSY
Fig. S22 1H-1H COSY spectrum (500 MHz, Chloroform-d) of compound 3
O
OH
H
HHH
O
OH
H
HHH
0.51.01.52.02.53.03.54.04.55.05.5f2 (ppm)
10
20
30
40
50
60
70
80
90
100
110
120
130
f1 (ppm)
XYG-X-90.5.ser
XYG-X-90 HSQC
Fig. S23 HSQC spectrum (500 MHz, Chloroform-d) of compound 3
0.51.01.52.02.53.03.54.04.55.05.56.0f2 (ppm)
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
f1 (ppm)
XYG-X-90.6.ser
XYG-X-90 HMBC
Fig. S24 HMBC spectrum (500 MHz, Chloroform-d) of compound 3
O
OH
H
HHH
O
OH
H
HHH
0.20.40.60.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.65.8f2 (ppm)
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
f1 (ppm)
XYG-X-90.7.ser
XYG-X-90 NOE
Fig. S25 NOESY spectrum (500 MHz, Chloroform-d) of compound 3
Fig. S26 HR-ESI-MSspectrum of compound 3
Fig. S27 IR (KBr disc) spectrum of compound 3
O
OH
H
HHH
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5f1 (ppm)
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
12000
13000
14000XYG-X-91.1.fid
XYG-X-91 1H NMR
6.60
4.10
3.24
3.48
3.08
2.26
1.42
1.95
1.70
2.96
3.46
2.17
2.49
2.11
1.41
1.00
1.21
1.38
1.25
0.98
0.99
1.20
1.02
1.00
1.00
0.8156
0.8252
0.8289
0.8385
0.8707
0.8843
0.8973
0.9107
0.9616
0.9751
1.0119
1.0249
1.2343
1.2426
1.2522
1.2618
1.2720
1.2755
1.2830
1.2855
1.2918
1.2960
1.4158
1.4399
1.4448
1.4690
1.5128
1.5179
1.5236
1.5331
1.5377
1.5420
1.5549
1.5587
1.6038
1.6118
1.6151
1.8003
1.8130
1.8265
1.8402
1.8528
1.9130
1.9226
1.9262
1.9297
1.9327
1.9364
1.9397
1.9430
1.9464
1.9566
1.9602
1.9702
2.0189
2.0232
2.0281
2.0328
2.0366
2.0409
2.0450
2.0498
2.0899
2.0976
2.1058
2.1143
2.1218
2.1291
2.1352
2.1587
2.2509
2.2593
2.2806
2.2889
2.3208
2.3273
2.3381
2.3447
2.3513
2.4354
2.4414
2.4465
2.4628
2.4712
2.4759
2.5881
2.6109
2.6277
2.6344
2.6417
2.6442
2.6820
2.6879
2.6987
2.7042
5.4901
Fig. S28 1H NMR spectrum (500 MHz, Chloroform-d) of compound 4
0102030405060708090100110120130140150160170180190200210220230240f1 (ppm)
-50
0
50
100
150
200
250
300
350
400
450
XYG-X-91.2.fid
XYG-X-91 C13 NMR
14.22
15.11
19.28
19.89
20.71
21.18
21.85
26.05
26.45
29.58
31.57
32.53
41.23
48.24
48.28
49.36
52.59
55.16
58.42
58.97
60.98
65.67
71.12
125.07
134.88
138.67
143.46
215.97
216.12
Fig. S29 13C NMR spectrum (125 MHz, Chloroform-d) of compound 4
O
OH
H
HHH
O
OH
H
HHH
101520253035404550556065707580859095100105110115120125130135f1 (ppm)
-2000
-1500
-1000
-500
0
500
1000
1500
2000
2500
3000
3500
XYG-X-91.3.fid
XYG-X-91 DEPT 135
14.22
15.12
19.28
19.89
20.71
21.19
21.85
26.05
26.45
29.58
31.57
32.53
41.23
48.23
48.27
49.36
52.59
55.16
58.42
58.97
65.67
71.11
125.07
Fig. S30 DEPT spectrum (125 MHz, Chloroform-d) of compound 4
0.51.01.52.02.53.03.54.04.55.05.5f2 (ppm)
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
f1 (ppm)
XYG-X-91.4.ser
XYG-X-91 1H 1H COSY
Fig. S31 1H-1H COSY spectrum (500 MHz, Chloroform-d) of compound 4
O
OH
H
HHH
O
OH
H
HHH
0.60.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.4f2 (ppm)
10
20
30
40
50
60
70
80
90
100
110
120
f1 (ppm)
XYG-X-91.5.ser
XYG-X-91 HSQC
Fig. S32 HSQC spectrum (500 MHz, Chloroform-d) of compound 4
0.51.01.52.02.53.03.54.04.55.05.5f2 (ppm)
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
f1 (ppm)
XYG-X-91.6.ser
XYG-X-91 HMBC
Fig. S33 HMBC spectrum (500 MHz, Chloroform-d) of compound 4
O
OH
H
HHH
O
OH
H
HHH
0.40.60.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.65.8f2 (ppm)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
f1 (ppm)
XYG-X-91.7.ser
XYG-X-91 NOE
Fig. S34 NOESY spectrum (500 MHz, Chloroform-d) of compound 4
Fig. S35 HR-ESI-MSspectrum of compound 4
Fig. S36 IR (KBr disc) spectrum of compound 4
O
OH
H
HHH
200 250 300 350 400
-60
-40
-20
0
20
40
60
CD
[mdg
e]
Wavelength [nm]
1 2
Fig. S37 CD spectrum of compounds 1 and 2
4
O
O
H-9a
H-7
H-10
H-1'
H-7'
NOE1H-1H COSY
Fig. S38 Key 1H-1H COSY and NOESY correlations of 4
200 250 300 350
-60
-40
-20
0
20
40
60
80
CD
[mde
g]
Wavelength [nm]
3 4
Fig. S39 CD spectrum of compounds 3 and 4
log cncentration (M )
Nitr
ite(u
m)
-6.5 -6.0 -5.5 -5.0 -4.5 -4.0 -3.50
10
20
30
40
50
4
Fig. S40 The dose inhibition curve of NO produced by compound 4. The data were obtained from three independent experiments and expressed as the means ± SEM.
(Method:0-16 min 20-45ACN;16-42 min,45-60 ACN; 42-57 min, 60-80ACN; 57-67 min,80-100 ACN; 67-70 min, 100 ACN). We have controlled the temperature during the whole isolation process. (T < 55 ºC).
7x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
+ESI TIC Scan Frag=135.0V 20180808-4.d
1 1
6x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6
+ESI BPC Scan Frag=135.0V 20180808-4.d
1 1
Counts vs. Acquisition Time (min)1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69
Fig S41 The TIC and BPC spectrum of the crude extracts from the roots of Xylopia vielana.
Fig S42 The HRESIMS of compound 1
Fig S43 The HRESIMS of compound 2
Fig S44 The HRESIMS of compound 3
Fig S45 The HRESIMS of compound 4